Ocugen Inc
OCGN1.005USD
+0.011+1.15%
交易中 （美東）報價延遲15分鐘
293.49M總市值
虧損本益比TTM
關於 Ocugen Inc 公司
Ocugen, Inc. 是一家生物製藥公司。該公司專注於發現、開發和商業化基因和細胞療法、生物製劑和疫苗，以改善全球患者的健康。其技術管道包括修飾基因治療平臺、再生醫學細胞治療平臺和視網膜疾病的生物療法。該公司正在開發其修飾基因治療平臺，包括 OCU400、OCU410 和 OCU410ST，用於治療多種遺傳性視網膜疾病 (IRD)，包括視網膜色素變性 (RP)、萊伯先天性黑蒙 (LCA)、Stargardt 病和多因素疾病，如干性年齡相關性黃斑變性 (dAMD) 和地圖狀萎縮 (GA)。它正在開發基於新型 ChAd 載體的吸入式粘膜疫苗平臺，其中包括 OCU500（一種 COVID-19 疫苗）；OCU510（一種季節性四價流感疫苗）；以及 OCU520，一種四價季節性流感和 COVID-19 聯合疫苗。
公司簡介
公司代碼OCGN
公司名稱Ocugen Inc
上市日期Dec 03, 2014
CEODr. Shankar Musunuri, Ph.D.
員工數量95
證券類型Ordinary Share
年結日Dec 03
公司地址11 Great Valley Parkway
城市MALVERN
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編19355
電話14843284701
網址https://ocugen.com/
公司代碼OCGN
上市日期Dec 03, 2014
CEODr. Shankar Musunuri, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+0.01%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+250.87%
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
75.00K
+50.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Huma Qamar, M.D.
Dr. Huma Qamar, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Uday B. Kompella, Ph.D.
Dr. Uday B. Kompella, Ph.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+0.01%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+250.87%
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
75.00K
+50.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
1.80K
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
收入明細
FY2025Q1
FY2024
FY2023
FY2021
FY2020
暫無數據
地區USD
名稱
營收
佔比
United States
1.48M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
6.24%
The Vanguard Group, Inc.
5.71%
Geode Capital Management, L.L.C.
2.36%
State Street Global Advisors (US)
2.03%
GMT Capital Corp.
1.42%
Other
82.24%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
6.24%
The Vanguard Group, Inc.
5.71%
Geode Capital Management, L.L.C.
2.36%
State Street Global Advisors (US)
2.03%
GMT Capital Corp.
1.42%
Other
82.24%
股東類型
持股股東
佔比
Investment Advisor
15.79%
Investment Advisor/Hedge Fund
6.52%
Hedge Fund
3.35%
Individual Investor
1.21%
Research Firm
0.74%
Corporation
0.39%
Bank and Trust
0.17%
Pension Fund
0.02%
Other
71.80%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
267
82.38M
28.21%
-9.38M
2025Q1
278
81.07M
27.89%
-11.63M
2024Q4
292
76.62M
26.34%
-21.25M
2024Q3
306
84.66M
29.43%
-6.14M
2024Q2
300
72.04M
27.84%
+19.28M
2024Q1
302
36.88M
14.47%
-15.26M
2023Q4
300
30.54M
12.06%
-31.79M
2023Q3
314
37.28M
14.69%
-34.75M
2023Q2
332
53.23M
20.91%
-28.29M
2023Q1
336
68.93M
30.49%
-36.35M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
18.22M
6.24%
-377.91K
-2.03%
Mar 31, 2025
The Vanguard Group, Inc.
16.68M
5.71%
+64.02K
+0.39%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.89M
2.36%
+300.41K
+4.56%
Mar 31, 2025
State Street Global Advisors (US)
5.93M
2.03%
+65.93K
+1.12%
Mar 31, 2025
GMT Capital Corp.
4.15M
1.42%
+1.70M
+69.20%
Mar 31, 2025
UBS Financial Services, Inc.
4.15M
1.42%
+3.42M
+469.31%
Mar 31, 2025
Renaissance Technologies LLC
3.46M
1.18%
+1.37M
+65.70%
Mar 31, 2025
Northern Trust Investments, Inc.
2.30M
0.79%
-103.69K
-4.31%
Mar 31, 2025
GSA Capital Partners LLP
1.64M
0.56%
+492.30K
+42.97%
Mar 31, 2025
Musunuri (Shankar Ph.D)
1.34M
0.46%
+607.32K
+82.50%
Apr 14, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.52%
iShares Micro-Cap ETF
0.01%
Pacer WealthShield ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.52%
iShares Micro-Cap ETF
佔比0.01%
Pacer WealthShield ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
